(VPG) Vishay Precision - Overview
Sector: Technology | Industry: Scientific & Technical Instruments | Exchange: NYSE (USA) | Market Cap: 1.303m USD | Total Return: 282.2% in 12m
Industry Rotation: -9.4
Avg Turnover: 20.0M
EPS Trend: -90.5%
Qual. Beats: -2
Rev. Trend: -69.2%
Qual. Beats: 1
Warnings
P/E ratio 217.7
Tailwinds
Supp Ema8, Supp Ema20, Leader, Tailwind, Pullback 52w, Confidence
Vishay Precision Group (VPG) is a manufacturer of precision measurement and sensing technologies, operating through three segments: Sensors, Weighing Solutions, and Measurement Systems. The company produces specialized components including precision resistors, strain gages, and load cells used for data acquisition and process control. Its diversified client base spans industrial, medical, agricultural, and consumer markets across North America, Europe, and Asia.
The company utilizes a multi-brand strategy, marketing its technology under various labels such as VFR, Celtron, and BLH Nobel to target specific niche applications. Within the electronic instruments sector, growth is frequently driven by the increasing demand for automation and high-accuracy data in industrial manufacturing processes. VPGs business model relies on the integration of proprietary foil technology into mission-critical systems where measurement failure can lead to significant operational downtime.
Investors can evaluate the company’s fundamental health and valuation trends by exploring the detailed analytics available on ValueRay.
Headquartered in Malvern, Pennsylvania, VPG serves as a specialized provider for industries requiring rigorous safety testing and metallurgical research. The company’s product portfolio includes advanced laser velocimeters and optical gages, which are essential for quality control in high-speed steel and paper production environments.
- Industrial manufacturing demand fluctuations impact high-precision sensor and resistor sales volume
- Global aerospace and defense spending cycles drive high-margin measurement systems revenue
- Raw material cost volatility and labor inflation pressure quarterly operating margins
- Expansion into medical and electric vehicle markets diversifies cyclical industrial revenue streams
- Capital expenditure trends in steel and electronics industries dictate equipment order backlogs
| Net Income: 5.92m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -2.43 > 1.0 |
| NWC/Revenue: 59.75% < 20% (prev 63.17%; Δ -3.42% < -1%) |
| CFO/TA 0.02 > 3% & CFO 8.54m > Net Income 5.92m |
| Net Debt (-38.1m) to EBITDA (27.9m): -1.36 < 3 |
| Current Ratio: 4.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (13.3m) vs 12m ago 0.30% < -2% |
| Gross Margin: 39.17% > 18% (prev 0.39%; Δ 3.88k% > 0.5%) |
| Asset Turnover: 70.47% > 50% (prev 65.55%; Δ 4.92% > 0%) |
| Interest Coverage Ratio: 6.90 > 6 (EBITDA TTM 27.9m / Interest Expense TTM 1.72m) |
| A: 0.42 (Total Current Assets 246.1m - Total Current Liabilities 55.0m) / Total Assets 453.8m |
| B: 0.43 (Retained Earnings 197.0m / Total Assets 453.8m) |
| C: 0.03 (EBIT TTM 11.8m / Avg Total Assets 453.8m) |
| D: 1.30 (Book Value of Equity 155.2m / Total Liabilities 119.4m) |
| Altman-Z'' Score: 5.72 = AAA |
| DSRI: 1.14 (Receivables 61.4m/50.2m, Revenue 319.8m/297.5m) |
| GMI: 1.01 (GM 39.17% / 39.49%) |
| AQI: 0.99 (AQ_t 0.24 / AQ_t-1 0.24) |
| SGI: 1.08 (Revenue 319.8m / 297.5m) |
| TATA: -0.01 (NI 5.92m - CFO 8.54m) / TA 453.8m) |
| Beneish M-Score: -2.86 (Cap -4..+1) = A |
Over the past week, the price has changed by +1.11%, over one month by +89.45%, over three months by +110.47% and over the past year by +282.20%.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 94.7 | -6% |
P/E Forward = 147.0588
P/S = 4.0737
P/B = 3.8923
P/EG = 7.3097
Revenue TTM = 319.8m USD
EBIT TTM = 11.8m USD
EBITDA TTM = 27.9m USD
Long Term Debt = 20.6m USD (from longTermDebt, last quarter)
Short Term Debt = 4.44m USD (from shortTermDebt, last quarter)
Debt = 44.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -38.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.26b USD (1.30b + Debt 44.4m - CCE 82.5m)
Interest Coverage Ratio = 6.90 (Ebit TTM 11.8m / Interest Expense TTM 1.72m)
EV/FCF = -1000.0x (Enterprise Value 1.26b / FCF TTM -1.05m)
FCF Yield = -0.08% (FCF TTM -1.05m / Enterprise Value 1.26b)
FCF Margin = -0.33% (FCF TTM -1.05m / Revenue TTM 319.8m)
Net Margin = 1.85% (Net Income TTM 5.92m / Revenue TTM 319.8m)
Gross Margin = 39.17% ((Revenue TTM 319.8m - Cost of Revenue TTM 194.6m) / Revenue TTM)
Gross Margin QoQ = 38.97% (prev 36.82%)
Tobins Q-Ratio = 2.79 (Enterprise Value 1.26b / Total Assets 453.8m)
Interest Expense / Debt = 0.74% (Interest Expense 329k / Debt 44.4m)
Taxrate = 39.27% (3.45m / 8.80m)
NOPAT = 7.19m (EBIT 11.8m * (1 - 39.27%))
Current Ratio = 4.47 (Total Current Assets 246.1m / Total Current Liabilities 55.0m)
Debt / Equity = 0.13 (Debt 44.4m / totalStockholderEquity, last quarter 334.7m)
Debt / EBITDA = -1.36 (Net Debt -38.1m / EBITDA 27.9m)
Debt / FCF = 36.39 (negative FCF - burning cash) (Net Debt -38.1m / FCF TTM -1.05m)
Total Stockholder Equity = 335.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.30% (Net Income 5.92m / Total Assets 453.8m)
RoE = 1.77% (Net Income TTM 5.92m / Total Stockholder Equity 335.0m)
RoCE = 3.33% (EBIT 11.8m / Capital Employed (Equity 335.0m + L.T.Debt 20.6m))
RoIC = 2.01% (NOPAT 7.19m / Invested Capital 358.3m)
WACC = 12.11% (E(1.30b)/V(1.35b) * Re(12.51%) + D(44.4m)/V(1.35b) * Rd(0.74%) * (1-Tc(0.39)))
Discount Rate = 12.51% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -28.89 | Cagr: -1.01%
[DCF] Fair Price = unknown (Cash Flow -1.05m)
EPS Correlation: -90.49 | EPS CAGR: -45.19% | SUE: -2.31 | # QB: -2
Revenue Correlation: -69.21 | Revenue CAGR: -1.31% | SUE: 2.87 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.19 | Chg30d=+72.73% | Revisions=+33% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.33 | Chg30d=+21.00% | Revisions=+33% | Analysts=3
EPS current Year (2026-12-31): EPS=1.01 | Chg30d=+27.43% | Revisions=+33% | GrowthEPS=+105.4% | GrowthRev=+13.9%
EPS next Year (2027-12-31): EPS=1.81 | Chg30d=+15.78% | Revisions=+33% | GrowthEPS=+79.8% | GrowthRev=+6.1%
[Analyst] Revisions Ratio: +33%